BAHR
Client SatisfactionBAHR has a solid track record advising multinational pharma companies, as well as clients in the energy, media, and telecoms sectors, on patent litigation and major IP transactions. The ‘very skilled’ Eirik Basmo Ellingsen was promoted to partner in 2023 and now heads up the team, while seasoned litigator Gunnar Sørlie has extensive experience handling high-profile patent disputes. Jacob A. Møller joined the team in March 2023; he leads the firm’s overall technology group and advises clients in the tech sector on various IP issues. Senior associate Anja Stensrud Elverum is another core name here. Are Stenvik left the firm in 2023 to become a Supreme Court justice.
Testimonials
Collated independently by Legal 500 research team.
‘Knowledgeable about IP law in Norway and EU. High availability. Able to understand commercial/strategic side of the customer and provide meaningful advice.’
‘Eirik Basmo Ellingsen is a very skilled lawyer with good understanding of his client’s needs and, of course, very knowledgeable in IP law. Always delivers on time.’
- 'Anja Elverum is a up-and-coming star within intellectual property law in Norway. She has an impressive overview of both the law and the details of the case.’
Key clients
- Amer Sports (Salomon S.A.S. and Atomic Austria GmbH)
- Baker Hughes
- Bayer
- Biogen
- Bristol-Myers Squibb
- Cisco
- Equinor
- Ewos AS
- Neurim Pharmaceuticals
- Novartis
- Oslo Philharmonic Orchestra
- REMA 1000
- Roche/Genentech
Work highlights
- Represented Stiftelsen Oslo-Filharmonien, one of Norway’s largest orchestras, in a high-profile copyright case before the Supreme Court.
- Representing Biogen in patent litigation before the Oslo District Court concerning the validity of the patent for Tecfidera.
- Represented Bristol-Myers Squibb in complex patent litigation concerning the blockbuster drug Eliquis.
Lawyers
Practice head
The lawyer(s) leading their teams.
Eirik Basmo Ellingsen